2021 GEOGRAPHICAL EXPANSION TO ASIA/PACIFIC REGION
FarmaMondo reinforces its presence in the APAC region by establishing a subsidiary in Hong Kong, aiming to serve patients’ needs in the region more effectively.
2021GEOGRAPHICAL EXPANSION TO IBERIA
FarmaMondo SA establishes its presence in Iberia by setting up a local subsidiary that is better placed to serve all Iberian HCPs and their patients’ needs and expectations.
2020Geographical Expansion to Argentina
FarmaMondo reinforces its presence in Latin America by establishing a subsidiary in Argentina aiming to enhance its infrastructure in Argentina, Chile, Uruguay and Paraguay.
2019Geographical Expansion to Mexico
FarmaMondo completes the establishment of its Mexican presence.
2018Geographical Expansion to the Baltic countries
FarmaMondo establishes a subsidiary in Lithuania to enhance its infrastructure in the Baltic region and Ukraine.
2017Geographical Expansion to the Nordic countries
FarmaMondo expands into the Nordic region by establishing its subsidiary in Denmark to cover the region’s five countries.
2014Pioneering Russia and the CIS region
FarmaMondo expands into Russia and the CIS region, becoming the pioneer of unlicensed medicines and specialty commercialization services in Russia.
2013 Going Global
FarmaMondo expands into Latin America, setting up its access and distribution infrastructures. The first international subsidiary of FarmaMondo is established in Brazil.
FarmaMondo SA and Farmacia Centrale are no longer a family-owned business. New leadership joins the company, led by a group of investors and experienced pharma entrepreneurs. A new era begins for FarmaMondo.
2008 First Managed Access Programme awarded for the Swiss market
FarmaMondo partners for the first time with an innovator seeking to establish a managed access programme to serve unmet named patient needs.
The '90s capabilities and regulations
70 years after its establishment, FarmaMondo has endured the test of time by always operating in a sustainable and responsible manner as any good Swiss business should. As medical needs and relevant regulations have evolved, so has FarmaMondo, becoming a solid pharmaceutical service business with a focus on supplying unlicensed medicines internationally.
The '80s the international evolution of FarmaMondo
With the introduction of the internet, FarmaMondo gains wide recognition as a major brand providing access to Swiss medicines. Through a simple web page offering access to medicines, FarmaMondo becomes the supply partner of many healthcare providers in Europe and Asia.
1982 Birth of FarmaMondo
Mr Bernasconi decides to expand the company’s export activities and establishes a Swiss holding company – FarmaMondo SA is born. Mr Bernasconi choses a brand name that reflects his vision of delivering access to pharmaceuticals at an international level. Farmacia Centrale lives on as a subsidiary of FarmaMondo SA, focusing exclusively on the local community.
Mr Bernasconi, a third-generation member of the Bernasconi family and a young pharmacist educated in Zurich, takes over the management of Farmacia Centrale.
1915 – 1970 Serving cross-border patient needs
The Swiss pharmaceutical market evolves during the 20th century to become one of most advanced globally. This leads to cross-border demand for Swiss therapies from patients and doctors in neighbouring Italy. Farmacia Centrale develops a cross-border supply chain to serve unmet needs from Italy and other nearby countries.
1915The founding year
Farmacia Centrale, the roots of the current FarmaMondo Group, is established as a private community pharmacy in the heart of the small Swiss border town of Chiasso. It is run by the Bernasconi family and serves the needs of the local population, numbering a few thousand.